Matthew David
2023
In 2023, Matthew David earned a total compensation of $1M as Chief Financial Officer at CorMedix, a 9% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $156,000 |
|---|---|
| Option Awards | $433,875 |
| Salary | $389,135 |
| Other | $52,140 |
| Total | $1,031,150 |
David received $433.9K in option awards, accounting for 42% of the total pay in 2023.
David also received $156K in non-equity incentive plan, $389.1K in salary and $52.1K in other compensation.
Rankings
In 2023, Matthew David's compensation ranked 1,177th out of 3,006 executives tracked by ExecPay. In other words, David earned more than 60.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,177 out of 3,006 | 61st |
Division Manufacturing | 702 out of 1,650 | 58th |
Major group Chemicals And Allied Products | 470 out of 918 | 49th |
Industry group Drugs | 459 out of 881 | 48th |
Industry Pharmaceutical Preparations | 316 out of 637 | 50th |
Source: SEC filing on October 8, 2024.
David's colleagues
We found three more compensation records of executives who worked with Matthew David at CorMedix in 2023.